Former Assistant District Attorney Indicted on Bribery, Money[...]
Baseline characteristics for INFRONT 3: A Phase 3 double blind, placebo[...]
Notification Letter and Reply Form to Non registered Shareholders[...]
08/11/2022 | Press release | Distributed by Public on 08/11/2022 06:03
Please select the service you want to use:
Smartlinks | OrthoPediatrics Corporation | News | Health | Medical Technology | Healthcare Equipment and Services | Medical Technology | Local News | Finance | Stock Markets | Security Markets | Stock Markets | Security Markets | Company News | Issue of Shares and Capital Increase | Public Share Offering | Manufacturing | Public Companies | Medical Supplies and Equipment Companies | Börse Frankfurt | NYSE American | NYSE ARCA Equities | Nasdaq Global Market | BZX Exchange | BYX Exchange | EDGA Exchange | EDGX Exchange | NYSE National | Nasdaq BX | Nasdaq PSX | FINRA Alternative Display Facility (ADF) | NYSE Chicago
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact